Dr. Simone Gold (@DrSimoneGold)

Pfizer is seeking "emergency authorization" for a second booster injection for people 65 and older. Just a reminder: The FDA was aware of almost 158,000 adverse events before it was granted “Emergency Use Authorization” according to the FDA’s own Pfizer clinical trial documents. Neither Pfizer nor the FDA disclosed until a Judge forced these docs to be released to the public.